QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

INSM

QT54Insmed Incorporated
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
95.80
-2.65-2.69%
OverviewShort InterestFilings
INSMQT54Insmed Incorporated·NASDAQ
OverviewShort InterestFilings
95.80-2.69%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-5.75
Insider Own0.99%
Shs Outstand216.75M
Perf Week-0.95%
Market Cap21.34BForward P/E231.73EPS next Y0.41Insider Trans0.10%Shs Float-Perf Month-10.81%
Enterprise Value21.51BPEG-EPS next Q-0.75Inst Own-Short Float-Perf Quarter-33.47%
Income-1190729280.00P/S26.04EPS this Y53.10%Inst Trans-Short Ratio-Perf Half Y-52.26%
Sales819.57MP/B30.10EPS next Y115.33%ROA-57.02%Short Interest-Perf YTD-44.96%
Book/sh3.25P/C-EPS next 5Y-ROE-130.11%52W High212.75 -54.97%Perf Year-4.47%
Cash/sh5.65P/FCF-EPS past 3/5Y-ROIC-65.28%52W Low90.39 5.99%Perf 3Y-
Dividend Est.-EV/EBITDA-19.89Sales past 3/5Y35.24% 29.88%Gross Margin81.56%Volatility3.17% 3.28%Perf 5Y-
Dividend TTM-EV/Sales26.24EPS Y/Y TTM-3.23%Oper. Margin-137.74%ATR (14)5.67Perf 10Y-
Dividend Ex-Date-Quick Ratio4.10Sales Y/Y TTM125.00%Profit Margin-144.44%RSI (14)38.15Recom2.13
Dividend Gr. 3/5Y-Current Ratio4.47EPS Q/Q46.48%SMA20-5.43%Beta0.61Target Price204.42
Payout0.00%Debt/Eq1.06Sales Q/Q229.03%SMA50-19.76%Rel Volume6.11Prev Close98.45
Employees1,271LT Debt/Eq1.01EarningsAug 06SMA200-37.62%Avg Volume3.82MPrice95.80
IPO DateJun 01, 2000Option/ShortYes / YesEPS/Sales Surpr.21.11% 1.66%Net Debt/EBITDA-0.15Volume23,342,392Change-2.69%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-16-26ReiteratedMizuho Securities$202 → $192
May-13-26ReiteratedTruist Financial$205 → $185
May-08-26ReiteratedGuggenheimBuy$230 → $226
May-08-26ReiteratedWells FargoOverweight$208 → $160
Apr-16-26ReiteratedGuggenheimBuy$227 → $230
Apr-14-26ReiteratedRBC CapitalOutperform$200 → $216
Apr-10-26InitiatedRaymond JamesOutperform$200
Apr-08-26ReiteratedMizuho Securities$206 → $202
Mar-30-26UpgradeMorgan StanleyEqual Weight → Overweight
Mar-26-26ReiteratedH.C. WainwrightBuy$230 → $245
Latest News
Jun-17-26
Jun-17-2606:11PM
Dear CoreWeave Stock Fans, Mark Your Calendars for June 22Yahoo
04:38PM
Jim Cramer Says SaaS Companies Like Zscaler “Have Fallen Viciously Out of Favor on Wall Street”Yahoo
Jun-16-26
Jun-16-2602:09PM
Why Is Nebius Stock Surging On Tuesday?Benzinga
Jun-12-26
Jun-12-2608:39PM
Stocks Rally on Hopes for a Near-term US-Iran Interim Peace AgreementYahoo
03:51PM
Stocks See Support from Hopes for a Near-term US-Iran Peace AgreementYahoo
02:28PM
Stocks See Support from Hopes for a Near-term US-Iran AgreementYahoo
02:10PM
Stocks See Downward Pressure Despite Hopes for a Near-term US-Iran AgreementYahoo
12:46PM
Five AI and Space Names Join the Nasdaq-100Yahoo
12:35PM
Nasdaq-100 Adds New AI and Space Winners. These Stocks Are SoaringYahoo
08:46AM
CoreWeave, Astera Labs, Nebius Group, And Others Added To Nasdaq-100: A 'Big Deal,' Says Jim CramerBenzinga
06:41AM
Why Is CoreWeave Stock Soaring Friday?Benzinga
12:00AM
Nasdaq-100 Index® June 2026 Quarterly ChangesYahoo
Jun-09-26
Jun-09-2601:22PM
Insmed Incorporated (INSM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeekingAlpha
01:22PM
Insmed Incorporated (INSM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeekingAlpha
09:39AM
Apple To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For TuesdayBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue819606364
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A15112586
Gross Profit668482278
Selling, General and Administrative Excl. Other800701461
Research and Development827771598
Other Operating Expense17018697
Operating Income-1,129-1,177-878
Interest Expense828485
Unusual Expense
———
Non-Operating Income (Expense)-2811-48
Net Income Before Taxes-1,178-1,272-910
Income Taxes554
Consolidated Net Income-1,184-1,277-914
Net Income From Continuing Operations-1,184-1,277-914
Net Income-1,184-1,277-914
EPS (Recurring)-5.75-6.41-5.57
EPS (Basic, Before Extraordinaries)-5.75-6.41-5.57
EPS (Diluted)-5.75-6.41-5.57
EBITDA-1,081-1,172-819
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio25.1561.46—
Gross Margin81.5679.5476.37
Operating Margin-137.85-194.22-241.21
Net Margin-144.57-210.73-251.10
Shares Outstanding215214164
Market Capitalization20,59737,245—
Operating Lease Expense
———
Insider Trading Volume
$104.94$95.06$85.19$75.32$65.44● Close Price0.00M11.12M22.23M33.35M44.47MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Lewis WilliamChair and CEOJun 08 '26Sale94.036,515612,605258,917Jun 10 12:00 AM
Flammer Martina M.D.Chief Medical OfficerJun 05 '26Sale103.781,858192,82360,486Jun 05 12:00 AM
Lewis WilliamChair and CEOJun 03 '26Sale102.277,605777,763265,432Jun 05 12:00 AM
Flammer Martina M.D.Chief Medical OfficerJun 03 '26Sale102.272,566262,42562,344Jun 05 12:00 AM
Adsett RogerChief Operating OfficerJun 03 '26Sale102.272,370242,38098,603Jun 05 12:00 AM
Bonstein SaraChief Financial OfficerJun 03 '26Sale102.272,404245,85769,082Jun 05 12:00 AM
Smith Michael AlexanderChief Legal OfficerJun 03 '26Sale102.272,159220,80139,454Jun 05 12:00 AM
Smith Michael AlexanderChief Legal OfficerMay 22 '26Sale108.476,149666,98241,613May 22 12:00 AM
Lewis WilliamChair and CEOMay 18 '26Option Exercise24.9421,398533,678298,601May 20 12:00 AM
Lewis WilliamChair and CEOMay 18 '26Sale106.3325,5642,718,224273,037May 20 12:00 AM
Flammer Martina M.D.Chief Medical OfficerMay 14 '26Sale117.5410,4791,231,70264,910May 15 12:00 AM
Adsett RogerChief Operating OfficerMay 13 '26Sale116.185,837678,143100,973May 15 12:00 AM
Flammer Martina M.D.Chief Medical OfficerMay 13 '26Sale114.237,854897,19075,389May 15 12:00 AM
Smith Michael AlexanderChief Legal OfficerMay 13 '26Sale116.184,109477,38447,762May 15 12:00 AM
Bonstein SaraChief Financial OfficerMay 13 '26Sale116.188,272961,04171,486May 15 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR